BioStock: Saniona's obesity drug one step closer to approval
The Mexican regulatory authority technical committee on new molecules has provided a favourable opinion on Saniona's drug candidate tesofensine for the treatment of obesity. BioStock reached out to CEO Thomas Feldthus for a comment.
Read the full interview with Thomas Feldthus at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/